Some consumer health advocates are staunchly opposed to a new bill that was unanimously approved by the House Energy and Commerce Committee on May 21, 2015. H.R. 6 is the 21st Century Cures Act that is being touted by its proponents as being a bipartisan reform package to facilitate medical... Read more »

Less than two weeks ago, the FDA released an important drug safety communication regarding a new class of diabetes drugs, including those marketed under the brand names Invokana, Farxiga and Jardiance. Health regulators caution that diabetic patients taking this class of sodium-glucose cotransporter-2 (SGLT2) inhibitors may be at risk for... Read more »

The Institute for Safe Medication Practices (ISMP) has relied in recent years on The U.S. Food and Drug Administration’s Adverse Event Reporting System, also known as FAERS, to generate data for its QuarterWatch drug safety reports. FAERS is the federal government’s primary watchdog program for identifying adverse patient events from... Read more »

Claims by plaintiffs in Benicar GI side effects lawsuits have recently been given support by a French study that was presented this past June at Digestive Disease Week in Chicago. The study brings to light just how great an impact using the blood pressure medication Benicar for a long term can... Read more »

The Los Angeles Superior Court is the site of a new product liability suit involving Bayer’s birth control pills marketed under the brand names Yaz and Yasmin. The controversial oral contraceptives, made with a fourth-generation progestin known to increase blood clot formation, have been associated with life-threatening health complications including... Read more »

The father of a twenty-nine year old New York resident, now deceased, is the plaintiff in a Propecia cognitive dysfunction lawsuit brought against the pharmaceutical giant, Merck & Co. for allegedly causing the wrongful death of his son. The suit was filed June 27, 2014 in United States District Court... Read more »

In the wake of an Actos bladder cancer lawsuit verdict in April of this year, Takeda Pharmaceuticals and its U.S. partner Eli Lilly are now seeking a new trial or a reversal of the judgment, which includes both $1.5 million in compensatory damages for the plaintiff and a combined $9... Read more »

Blue Cross/ Blue Shield of Massachusetts has taken legal action against pharmaceutical giant Takeda, claiming the company failed to warn consumers and the medical community about the association between Actos and bladder cancer. The healthcare provider is now seeking compensation for costs of bladder cancer treatment for hundreds of their... Read more »

All testosterone therapy lawsuits filed in U.S. District Courts nationwide, alleging injuries because of Low T treatments, will now go before one judge in the Northern District of Illinois in centralized litigation known as “multidistrict litigation” or MDL. This move comes on the heels of June 6 order by a... Read more »

Angiotensin II type 1 receptor blockers (ARBs) are commonly used in the treatment of hypertension (high blood pressure) and heart failure. Benicar, manufactured by Daiichi Sankyo, is one of the more widely prescribed ARBs since its FDA approval in 2002. Also known by its generic name olmesartan medoxomil, Benicar has... Read more »